Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α.

Mucci JM, Scian R, De Francesco PN, García FS, Ceci R, Fossati CA, Delpino MV, Rozenfeld PA.

Gene. 2012 Nov 1;509(1):51-9. doi: 10.1016/j.gene.2012.07.071. Epub 2012 Aug 6.

PMID:
23010424
2.

Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.

Mucci JM, Suqueli García F, de Francesco PN, Ceci R, Di Genaro S, Fossati CA, Delpino MV, Rozenfeld PA.

Gene. 2013 Dec 15;532(2):186-91. doi: 10.1016/j.gene.2013.09.072. Epub 2013 Sep 26.

PMID:
24076352
3.

Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology.

Mucci JM, Cuello MF, Kisinovsky I, Larroude M, Delpino MV, Rozenfeld PA.

Blood Cells Mol Dis. 2015 Aug;55(2):134-43. doi: 10.1016/j.bcmd.2015.05.009. Epub 2015 May 27.

PMID:
26142329
4.

IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.

Morita Y, Kitaura H, Yoshimatsu M, Fujimura Y, Kohara H, Eguchi T, Yoshida N.

Calcif Tissue Int. 2010 Mar;86(3):242-8. doi: 10.1007/s00223-010-9335-6. Epub 2010 Jan 29.

PMID:
20111957
5.

IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.

Kohara H, Kitaura H, Fujimura Y, Yoshimatsu M, Morita Y, Eguchi T, Masuyama R, Yoshida N.

Immunol Lett. 2011 Jun 30;137(1-2):53-61. doi: 10.1016/j.imlet.2011.02.017. Epub 2011 Feb 19.

PMID:
21338623
6.

Brucella abortus-infected macrophages modulate T lymphocytes to promote osteoclastogenesis via IL-17.

Giambartolomei GH, Scian R, Acosta-Rodríguez E, Fossati CA, Delpino MV.

Am J Pathol. 2012 Sep;181(3):887-96. doi: 10.1016/j.ajpath.2012.05.029.

PMID:
22901753
7.
8.

Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease.

Reed M, Baker RJ, Mehta AB, Hughes DA.

Blood Cells Mol Dis. 2013 Oct;51(3):185-94. doi: 10.1016/j.bcmd.2013.04.006. Epub 2013 May 23.

PMID:
23707505
9.

Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.

Roato I, Grano M, Brunetti G, Colucci S, Mussa A, Bertetto O, Ferracini R.

FASEB J. 2005 Feb;19(2):228-30. Epub 2004 Nov 18.

10.

Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.

Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J.

J Bone Miner Res. 2004 Nov;19(11):1905-16. Epub 2004 Sep 27.

11.

Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues.

Roato I, Caldo D, D'Amico L, D'Amelio P, Godio L, Patanè S, Astore F, Grappiolo G, Boggio M, Scagnelli R, Molfetta L, Ferracini R.

Biomaterials. 2010 Oct;31(29):7519-25. doi: 10.1016/j.biomaterials.2010.06.027. Epub 2010 Jul 17.

PMID:
20638717
12.

Bone marrow microenvironment in an in vitro model of Gaucher disease: consequences of glucocerebrosidase deficiency.

Lecourt S, Vanneaux V, Cras A, Freida D, Heraoui D, Herbi L, Caillaud C, Chomienne C, Marolleau JP, Belmatoug N, Larghero J.

Stem Cells Dev. 2012 Jan 20;21(2):239-48. doi: 10.1089/scd.2011.0365. Epub 2011 Oct 18.

PMID:
21867425
13.

Osteoclasts: what do they do and how do they do it?

Teitelbaum SL.

Am J Pathol. 2007 Feb;170(2):427-35.

14.

The molecular basis of osteoclast differentiation and activation.

Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N.

Novartis Found Symp. 2001;232:235-47; discussion 247-50. Review.

PMID:
11277084
15.

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Kanazawa K, Kudo A.

J Bone Miner Res. 2005 May;20(5):840-7. Epub 2004 Dec 20.

16.

Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages.

Shimizu S, Okuda N, Kato N, Rittling SR, Okawa A, Shinomiya K, Muneta T, Denhardt DT, Noda M, Tsuji K, Asou Y.

Arthritis Rheum. 2010 May;62(5):1329-37. doi: 10.1002/art.27400.

17.
18.

Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL.

J Clin Invest. 1997 Sep 15;100(6):1557-65.

19.

In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.

Prence EM, Chaturvedi P, Newburg DS.

J Neurosci Res. 1996 Feb 1;43(3):365-71.

PMID:
8714525
20.

Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis.

Nason R, Jung JY, Chole RA.

J Assoc Res Otolaryngol. 2009 Jun;10(2):151-60. doi: 10.1007/s10162-008-0153-8. Epub 2009 Jan 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk